Asymmetrex Proposes “Stemgene Therapy” to Emphasize the Importance of...

The founder and director of stem cell biotechnology company Asymmetrex, James L. Sherley, M.D., Ph.D., continues to lead the company’s public service mission of disseminating timely scientific...(PRWeb July 24, 2018)Read the full story at https://www.prweb.com/releases/asymmetrex_proposes_stemgene_therapy_to_emphasize_the_importance_of_tissue_stem_cells_for_successful_gene_therapy/prweb15643127.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news